D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VGR
2376
DELISTED
Vector Group Ltd.
VGR
| $1.36M | ﹤0.01% |
186,770
+163,362
| +698% | +$1.21M |
|
|
SC
2377
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $1.35M | ﹤0.01% |
64,063
-158,942
| -71% | -$3.17M |
|
|
SWCH
2378
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $1.35M | ﹤0.01% |
+130,615
| New | +$1.13M |
|
|
BEST
2379
DELISTED
BEST Inc. American Depositary Shares, each representing twenty (20) Class A Ordinary Shares
BEST
| $1.34M | ﹤0.01% |
12,853
+11,552
| +888% | +$1.2M |
|
2380
CALL
Valmont Industries
VMI
$9.3B
| $1.34M | ﹤0.01% |
10,300
+6,400
| +164% | +$826K |
|
|
ALXN
2381
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.34M | ﹤0.01% |
9,900
-1,700
| -15% | -$211K |
|
|
INVX
2382
Innovex International
INVX
$1.96B
| $1.33M | ﹤0.01% |
28,957
-72,057
| -71% | -$2.83M |
|
|
ROCC
2383
CALL
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.33M | ﹤0.01% |
30,100
-12,600
| -30% | -$675K |
|
2384
Box
BOX
$4.37B
| $1.32M | ﹤0.01% |
+68,338
| New | +$1.42M |
|
|
IPG
2385
DELISTED
Interpublic Group of Companies
IPG
| $1.32M | ﹤0.01% |
62,830
-88,438
| -58% | -$1.97M |
|
|
BZUN
2386
Baozun
BZUN
$167M
| $1.32M | ﹤0.01% |
31,760
-5,478
| -15% | -$192K |
|
|
FCRD
2387
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| $1.32M | ﹤0.01% |
200,937
+146,146
| +267% | +$982K |
|
|
I
2388
DELISTED
INTELSAT S. A.
I
| $1.32M | ﹤0.01% |
84,020
-209,842
| -71% | -$4.45M |
|
2389
American Express
AXP
$227B
| $1.31M | ﹤0.01% |
12,019
+1,362
| +13% | +$143K |
|
2390
Domo
DOMO
$174M
| $1.31M | ﹤0.01% |
32,557
+14,576
| +81% | +$447K |
|
2391
Lexicon Pharmaceuticals
LXRX
$1.03B
| $1.31M | ﹤0.01% |
236,121
-32,355
| -12% | -$197K |
|
|
IMGN
2392
DELISTED
Immunogen Inc
IMGN
| $1.31M | ﹤0.01% |
+483,839
| New | +$2.1M |
|
2393
PUT
Insmed
INSM
$21.4B
| $1.31M | ﹤0.01% |
45,000
| – | – |
|
2394
Old Dominion Freight Line
ODFL
$44.1B
| $1.31M | ﹤0.01% |
27,153
-10,533
| -28% | -$492K |
|
|
WLH
2395
PUT
DELISTED
WILLIAM LYON HOMES
WLH
| $1.31M | ﹤0.01% |
85,000
| – | – |
|
2396
CALL
VF Corp
VFC
$5.63B
| $1.3M | ﹤0.01% |
15,930
-25,276
| -61% | -$1.97M |
|
2397
Lands' End
LE
$370M
| $1.3M | ﹤0.01% |
78,144
+57,792
| +284% | +$985K |
|
|
NVMI
2398
Nova
NVMI
$12.4B
| $1.3M | ﹤0.01% |
+51,529
| New | +$1.25M |
|
2399
PUT
Deutsche Bank
DB
$69B
| $1.3M | ﹤0.01% |
159,700
-128,200
| -45% | -$1.12M |
|
2400
CALL
Alaska Air
ALK
$5.29B
| $1.3M | ﹤0.01% |
23,100
-10,800
| -32% | -$659K |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.